Inhibitors of protein tyrosine kinases
β
David W Fry; Alexander J Bridges
π
Article
π
1995
π
Elsevier Science
π
English
β 745 KB
The description in the past year of several novel protein tyrosine kinase inhibitors, which exhibit dramatic improvements in potency and specificity over earlier agents, will be considered a major turning point in the field. These compounds appear to have the necessary pharmacological properties to